Total Payments
$12,129
2024 Payments
$1,589
Companies
45
Transactions
770
Medicare Patients
10,069
Medicare Billing
$493,062
Payment Breakdown by Category
Food & Beverage$11,980 (98.8%)
Education$149.00 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,980 | 763 | 98.8% |
| Education | $149.00 | 7 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,259 | 116 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,644 | 128 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $932.18 | 51 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $913.39 | 60 | $0 (2024) |
| Amgen Inc. | $882.13 | 46 | $0 (2024) |
| ABBVIE INC. | $716.43 | 45 | $0 (2024) |
| Merck Sharp & Dohme LLC | $671.59 | 65 | $0 (2024) |
| Lilly USA, LLC | $569.56 | 49 | $0 (2024) |
| PFIZER INC. | $472.11 | 34 | $0 (2024) |
| Abbott Laboratories | $391.09 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,589 | 79 | Novo Nordisk Inc ($432.64) |
| 2023 | $1,568 | 88 | Novo Nordisk Inc ($424.80) |
| 2022 | $1,916 | 113 | Novo Nordisk Inc ($399.62) |
| 2021 | $1,155 | 84 | AbbVie Inc. ($207.98) |
| 2020 | $1,082 | 80 | GlaxoSmithKline, LLC. ($246.38) |
| 2019 | $1,482 | 102 | Novo Nordisk Inc ($390.20) |
| 2018 | $1,702 | 102 | GlaxoSmithKline, LLC. ($233.84) |
| 2017 | $1,635 | 122 | Boehringer Ingelheim Pharmaceuticals, Inc. ($345.81) |
All Payment Transactions
770 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Obesity | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Diabetes Care | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.11 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $22.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: VACCINES | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $3.85 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Bone Health | ||||||
| 09/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Obesity | ||||||
| 08/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Inflammation | ||||||
| 08/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $102.85 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 3,028 | 3,831 | $532,153 | $150,895 |
| 2022 | 43 | 2,793 | 3,491 | $658,308 | $138,176 |
| 2021 | 44 | 2,455 | 3,013 | $616,183 | $126,158 |
| 2020 | 30 | 1,793 | 2,324 | $453,193 | $77,833 |
Total Patients
10,069
Total Services
12,659
Medicare Billing
$493,062
Procedure Codes
164
All Medicare Procedures & Services
164 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 317 | 582 | $88,464 | $43,566 | 49.2% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 142 | 143 | $195,094 | $18,910 | 9.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 67 | 67 | $16,281 | $10,281 | 63.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 77 | 77 | $16,863 | $9,111 | 54.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 111 | 111 | $18,093 | $8,071 | 44.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 65 | $13,325 | $7,784 | 58.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $6,270 | $5,360 | 85.5% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 46 | 46 | $43,084 | $4,241 | 9.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 58 | 58 | $8,061 | $4,169 | 51.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 76 | $7,828 | $3,761 | 48.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 264 | 412 | $7,836 | $3,438 | 43.9% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 21 | 21 | $7,392 | $2,935 | 39.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 205 | 256 | $9,708 | $2,650 | 27.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 168 | 201 | $11,466 | $2,637 | 23.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 44 | 44 | $6,952 | $2,635 | 37.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 153 | 153 | $6,851 | $2,589 | 37.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 237 | 327 | $11,122 | $2,438 | 21.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 96 | 117 | $8,522 | $1,926 | 22.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 60 | 60 | $2,160 | $1,706 | 79.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $2,596 | $1,678 | 64.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 78 | 78 | $2,418 | $1,320 | 54.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 35 | 36 | $4,140 | $1,044 | 25.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 86 | 110 | $6,996 | $1,039 | 14.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 42 | 44 | $3,344 | $948.71 | 28.4% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 43 | 43 | $3,956 | $813.56 | 20.6% |
About Dr. Derek Mullinix, MD
Dr. Derek Mullinix, MD is a Family Medicine healthcare provider based in Bartlett, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689628323.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Derek Mullinix, MD has received a total of $12,129 in payments from pharmaceutical and medical device companies, with $1,589 received in 2024. These payments were reported across 770 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($11,980).
As a Medicare-enrolled provider, Mullinix has provided services to 10,069 Medicare beneficiaries, totaling 12,659 services with total Medicare billing of $493,062. Data is available for 4 years (2020–2023), covering 164 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bartlett, TN
- Active Since 05/19/2006
- Last Updated 10/25/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1689628323
Products in Payments
- TRELEGY ELLIPTA (Drug) $907.27
- Ozempic (Drug) $733.99
- UBRELVY (Drug) $541.77
- JARDIANCE (Drug) $442.23
- Rybelsus (Drug) $415.55
- JANUVIA (Drug) $388.68
- Aimovig (Biological) $374.19
- BREZTRI (Drug) $330.37
- FARXIGA (Drug) $321.78
- TRADJENTA (Drug) $244.34
- NURTEC ODT (Drug) $231.91
- Otezla (Drug) $229.60
- XIFAXAN (Drug) $228.75
- FREESTYLE LIBRE 2 (Device) $199.69
- EMGALITY (Drug) $199.10
- Vascepa (Drug) $178.49
- ANORO (Drug) $166.23
- TRINTELLIX (Drug) $153.20
- Kerendia (Drug) $144.48
- Trulance (Drug) $142.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bartlett
Charolette Jackson, Md, MD
Family Medicine — Payments: $156,652
Family Medicine $156,652
Terri Hyatt, Md, MD
Family Medicine — Payments: $16,950
Family Medicine $16,950
Michele Neal, Md, MD
Family Medicine — Payments: $16,710
Family Medicine $16,710
Joseph Wong, Md, MD
Family Medicine — Payments: $15,767
Family Medicine $15,767
Robert Miller, Md, MD
Family Medicine — Payments: $13,769
Family Medicine $13,769
Dr. Jose Gabriel Ongsingco, Md, MD
Family Medicine — Payments: $13,672
Family Medicine $13,672